Search alternatives:
significant component » significant amount (Expand Search)
significantly linked » significantly longer (Expand Search), significantly altered (Expand Search), significantly changed (Expand Search)
component decrease » component discrete (Expand Search)
linked decreased » marked decrease (Expand Search), linear decrease (Expand Search), showed decreased (Expand Search)
Showing 1 - 20 results of 10,056 for search '(( significantly linked decreased ) OR ( significant component decrease ))', query time: 0.57s Refine Results
  1. 1
    ACT and ISO decrease pathological changes in LPS-induced AKI mice.

    ACT and ISO decrease pathological changes in LPS-induced AKI mice. by Jing Lian (1671991)

    Published 2024
    Save to List
    Saved in:
  2. 2
    Interaction of significantly changed genes and their linked pathways.

    Interaction of significantly changed genes and their linked pathways. by Mohamad Ammar Ayass (13775290)

    Published 2022
    Save to List
    Saved in:
  3. 3
    CRISPRi knockdown of RgaR-dependent genes specifically and significantly decreases their transcript levels.

    CRISPRi knockdown of RgaR-dependent genes specifically and significantly decreases their transcript levels. by Adrianne N. Edwards (5646344)

    Published 2023
    Save to List
    Saved in:
  4. 4
    Significant cholesterol genes arranged by day.

    Significant cholesterol genes arranged by day. by Katherine M. Peterson (19746455)

    Published 2024
    “…Genes with increased expression are blue; genes with decreased expression are orange; the depth of color reflects the magnitude of the increase or decrease. …”
    Save to List
    Saved in:
  5. 5
    Decrease in VACV infectivity linked to defect in viral entry.

    Decrease in VACV infectivity linked to defect in viral entry. by Lalita Priyamvada (421536)

    Published 2022
    Save to List
    Saved in:
  6. 6
    DICER protein expression is significantly decreased in the absence of MOV10 and FMRP.

    DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. by Monica C. Lannom (11772729)

    Published 2021
    Save to List
    Saved in:
  7. 7
    PCoA plot analysis for dissimilarity.

    PCoA plot analysis for dissimilarity. by Yu Sang Choi (22656230)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    A. Representative data of NB4 cells (treated with LPS and RSV) ETOsis percentage by Flow cytometry method. NB4 cells are stimulated with LPS (1). NB4 cells are treated with 5 µ M RSV (2). NB4 cells are treated with 10 µ M RSV. **p < 0.01. In comparison to the condition in which the cells were treated with the stimulant (LPS) alone, 5 and 10 μM resveratrol significantly reduced ETosis. B. Results of flowcytometry analysis.

    A. Representative data of NB4 cells (treated with LPS and RSV) ETOsis percentage by Flow cytometry method. NB4 cells are stimulated with LPS (1). NB4 cells are treated with 5 µ M R... by Mahshid Vafajoo (21144147)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Differences among lymphocyte subsets between non-LN JSLE patients, LN JSLE patients, and HC.

    Differences among lymphocyte subsets between non-LN JSLE patients, LN JSLE patients, and HC. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 10
    Regulatory T cells in JSLE patients, stratified into treatment-naïve and treated groups during 6-months follow-up.

    Regulatory T cells in JSLE patients, stratified into treatment-naïve and treated groups during 6-months follow-up. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 11
    Lymphocyte subset distribution during longitudinal follow-up in JSLE patients, stratified into treatment-naïve and treated groups.

    Lymphocyte subset distribution during longitudinal follow-up in JSLE patients, stratified into treatment-naïve and treated groups. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 12
    Regulatory T cells in JSLE patients during 6-months follow-up.

    Regulatory T cells in JSLE patients during 6-months follow-up. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 13
    Kaplan–Meier analysis of clinical remission in juvenile-onset systemic lupus erythematosus patients.

    Kaplan–Meier analysis of clinical remission in juvenile-onset systemic lupus erythematosus patients. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 14
    Differences among lymphocyte subsets between JSLE patients and HC.

    Differences among lymphocyte subsets between JSLE patients and HC. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 15
    Associations between lymphocyte subsets and clinical manifestations in juvenile-onset systemic lupus erythematosus.

    Associations between lymphocyte subsets and clinical manifestations in juvenile-onset systemic lupus erythematosus. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 16
    Predictors of remission on therapy in the juvenile-onset systemic lupus erythematosus patients.

    Predictors of remission on therapy in the juvenile-onset systemic lupus erythematosus patients. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 17
    Demographic, clinical, and laboratory parameters of the juvenile-onset systemic lupus erythematosus patients.

    Demographic, clinical, and laboratory parameters of the juvenile-onset systemic lupus erythematosus patients. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 18
    Stratification of the juvenile-onset systemic lupus erythematosus patients by the median percentage of each lymphocyte subset.

    Stratification of the juvenile-onset systemic lupus erythematosus patients by the median percentage of each lymphocyte subset. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 19
    Lymphocyte subset distribution during longitudinal follow-up in JSLE patients.

    Lymphocyte subset distribution during longitudinal follow-up in JSLE patients. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 20
    Percentages of lymphocyte subsets in the juvenile-onset systemic lupus erythematosus patients.

    Percentages of lymphocyte subsets in the juvenile-onset systemic lupus erythematosus patients. by Butsabong Lerkvaleekul (12055191)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: